199 related articles for article (PubMed ID: 34580954)
1. Reduced ELANE and SLPI expression compromises dental pulp cell activity.
Sriwattanapong K; Sa-Ard-Iam N; Boonprakong L; Subbalekha K; Trachoo V; Suratannon N; Porntaveetus T; Shotelersuk V
Cell Prolif; 2021 Nov; 54(11):e13132. PubMed ID: 34580954
[TBL] [Abstract][Full Text] [Related]
2. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
[TBL] [Abstract][Full Text] [Related]
3. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia.
Ye Y; Carlsson G; Wondimu B; Fahlén A; Karlsson-Sjöberg J; Andersson M; Engstrand L; Yucel-Lindberg T; Modéer T; Pütsep K
J Clin Immunol; 2011 Dec; 31(6):936-45. PubMed ID: 21796505
[TBL] [Abstract][Full Text] [Related]
5. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia.
Nustede R; Klimiankou M; Klimenkova O; Kuznetsova I; Zeidler C; Welte K; Skokowa J
Br J Haematol; 2016 Jan; 172(2):219-27. PubMed ID: 26567890
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of severe congenital neutropenia caused by novel ELANE gene mutations.
Shu Z; Li XH; Bai XM; Zhang ZY; Jiang LP; Tang XM; Zhao XD
Pediatr Infect Dis J; 2015 Feb; 34(2):203-7. PubMed ID: 25162927
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.
Tran NT; Graf R; Wulf-Goldenberg A; Stecklum M; Strauß G; Kühn R; Kocks C; Rajewsky K; Chu VT
Mol Ther; 2020 Dec; 28(12):2621-2634. PubMed ID: 32822592
[TBL] [Abstract][Full Text] [Related]
8. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
Qiu Y; Zhang Y; Hu N; Dong F
J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil Elastase Defects in Congenital Neutropenia.
Rydzynska Z; Pawlik B; Krzyzanowski D; Mlynarski W; Madzio J
Front Immunol; 2021; 12():653932. PubMed ID: 33968054
[TBL] [Abstract][Full Text] [Related]
10. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.
Horwitz MS; Corey SJ; Grimes HL; Tidwell T
Hematol Oncol Clin North Am; 2013 Feb; 27(1):19-41, vii. PubMed ID: 23351986
[TBL] [Abstract][Full Text] [Related]
11. PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations.
Olofsen PA; Bosch DA; Roovers O; van Strien PMH; de Looper HWJ; Hoogenboezem RM; Barnhoorn S; Mastroberardino PG; Ghazvini M; van der Velden VHJ; Bindels EMJ; de Pater EM; Touw IP
Blood Adv; 2021 Feb; 5(3):775-786. PubMed ID: 33560392
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and genetic analysis of two patients with congenital neutropenia caused by ELANE gene mutation].
Liu H; Liu G; Zhao P; Huang L; Zhou Y; Qiu X; Xu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1097-1101. PubMed ID: 32924109
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
[TBL] [Abstract][Full Text] [Related]
14. Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.
van de Vosse E; Verhard EM; Tool AJ; de Visser AW; Kuijpers TW; Hiemstra PS; van Dissel JT
Ann Hematol; 2011 Feb; 90(2):151-8. PubMed ID: 20803142
[TBL] [Abstract][Full Text] [Related]
15. A patient with severe congenital neutropenia harbors a missense ELANE mutation due to paternal germline mosaicism.
Ying Y; Ye J; Chen Y; Chen Q; Chen Y; Lu X; Xi H; Gu F; Pan D; Zhao J
Clin Chim Acta; 2022 Feb; 526():14-20. PubMed ID: 34968504
[TBL] [Abstract][Full Text] [Related]
16. Severe congenital neutropenia with elastase, neutrophil expressed (ELANE) gene mutation in a Tanzanian child.
Shoo A; Swai P; Kindole C; Ngailo E; Godfrey E; Massawe E; Warren AJ; Luzzatto L
Br J Haematol; 2022 Mar; 196(5):1271-1274. PubMed ID: 34725814
[No Abstract] [Full Text] [Related]
17. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
Germeshausen M; Deerberg S; Peter Y; Reimer C; Kratz CP; Ballmaier M
Hum Mutat; 2013 Jun; 34(6):905-14. PubMed ID: 23463630
[TBL] [Abstract][Full Text] [Related]
18. Severe congenital neutropenia: new lane for ELANE.
Borregaard N
Blood; 2014 Jan; 123(4):462-3. PubMed ID: 24458273
[TBL] [Abstract][Full Text] [Related]
19. Dissecting ELANE neutropenia pathogenicity by human HSC gene editing.
Rao S; Yao Y; Soares de Brito J; Yao Q; Shen AH; Watkinson RE; Kennedy AL; Coyne S; Ren C; Zeng J; Serbin AV; Studer S; Ballotti K; Harris CE; Luk K; Stevens CS; Armant M; Pinello L; Wolfe SA; Chiarle R; Shimamura A; Lee B; Newburger PE; Bauer DE
Cell Stem Cell; 2021 May; 28(5):833-845.e5. PubMed ID: 33513358
[TBL] [Abstract][Full Text] [Related]
20. Elastase inhibitors as potential therapies for
Makaryan V; Kelley ML; Fletcher B; Bolyard AA; Aprikyan AA; Dale DC
J Leukoc Biol; 2017 Oct; 102(4):1143-1151. PubMed ID: 28754797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
